Trials / Completed
CompletedNCT02139033
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome
A Single-Center Evaluation of Retaine™ Ophthalmic Emulsion in the Management of Tear Film Stability and Ocular Surface Staining in Patients Diagnosed With Dry Eye
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Ocusoft, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of Retaine™ ophthalmic emulsion in treating the signs and symptoms of dry eye syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Retaine™ |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-05-15
- Last updated
- 2014-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02139033. Inclusion in this directory is not an endorsement.